Email is not displaying correctly? View it in your browser.

September 20, 2021

Goldsmith named co-leader of DDT Program

Kelly C. Goldsmith, MD, a physician-scientist specializing in pediatric oncology, has been named co-leader of the Discovery and Developmental Therapeutics (DDT) Program, one of Winship’s four research programs. Effective September 20, 2021, Goldsmith will serve in this role alongside Haian Fu, PhD, who has led the DDT Program since 2010.

Awards support Winship nurses’ career and educational goals

Winship has announced the 2021 recipients of the Sabrina Williams Oncology Nursing Education Award and the Katie Ferraris Taylor Oncology Nursing Fund Award. Each award was established by the families of Winship patients as an enduring way to recognize and support the vital role of oncology nurses.

Dhodapkar elected to AACR steering committee

Kavita Dhodapkar, MD, has been elected to the Steering Committee of the American Association for Cancer Research (AACR) Cancer Immunology Working Group. The Steering Committee establishes working group priorities to accelerate the prevention, detection, treatment, and survivorship of cancer. 

About the Steering Committee

Perspectives on Women in Medicine Month

This September, in honor of Women in Medicine Month, Winship healthcare professionals are sharing reflections on working at Winship and what their careers have been like as women in medicine. Drs. Keerthi Gogineni and Jacqueline Brown discuss their paths, and what they've learned along the way, in the next series of Women in Medicine Month perspectives.

Keerthi Gogineni, MD, MSHP

Associate Professor, Department of Hematology and Medical Oncology

Jacqueline Brown, MD

Assistant Professor, Department of Hematology and Medical Oncology

Renovations underway to expand services at Winship's Clifton location

Significant renovations are underway to enhance patient service offerings and improve overall flow for patients and staff on the first floor at Winship’s Clifton campus location. The project reflects a continued commitment to the Winship Way, an innovative patient centric approach to cancer care.

Leal joins Department of Hematology & Medical Oncology

Ticiana Leal, MD, has joined Winship as an associate professor of hematology and medical oncology. Leal specializes in the care of patients with lung cancer, mesothelioma and thymic malignancies, and will serve as director of the department’s Thoracic Medical Oncology Program.

View Profile

Curran named to list of Giants of Cancer Care

Walter J. Curran, Jr., MD, who served as Winship's executive director from 2009 to 2021, is among this year's OncLive Giants of Cancer Care® inductees in the radiation oncology category. The program celebrates oncology luminaries for their groundbreaking achievements in cancer research and clinical practice.

Cardiac Tumor Program at Emory one of few in the U.S.

The Cardiac Tumor Program at Emory, a collaboration between Winship and the Emory Heart and Vascular Center, is one of the few such programs in the country. Led by Drs. Anant Mandawat and Mani Daneshmand, the program's multidisciplinary team evaluates, diagnoses, and treats patients and helps them navigate this complex disease.

Learn More

Bramble named Fellow of the American College of Healthcare Executives

Vanessa Bramble, MS, MBA, CRA, RT (R)(M), Winship's director of network development, has been named a Fellow of the American College of Healthcare Executives, a professional society for healthcare leaders. ACHE fellows must pass a certifying examination and fulfill rigorous educational, professional, and service requirements.

About ACHE

Webinar: Reducing Health Care Disparities in Prostate Cancer

The Georgia Association of Clinical Oncology (GASCO) will host a free webinar, “Reducing Health Care Disparities in Prostate Cancer,” on Sept. 27. Speakers include Winship prostate cancer specialists Drs. Bradley Carthon, Jay Shelton, and Vikram M. Narayan.

Monthly K-Club meetings return for Fall

K-Club is an educational forum to assist fellows and faculty with successful research grant applications, with an emphasis on NIH career development (K grant) awards. The next monthly K-Club meeting, taking place at noon on Sept. 20, will provide an overview of research career development resources and programs.

Call for proposals: BDCI Accelerator Grants

The Biological Discovery through Chemical Innovation (BDCI) Accelerator Grants are one-year, $40,000 awards that support new, collaborative projects at the interface of biology, chemistry, and human health. Open to faculty, research specialists, and staff scientists, applications are due Nov. 30.

Learn More

Emory OPEN: Where Emory meets Atlanta

Emory faculty, staff, alumni, and students can now find local volunteer opportunities on the new Emory OPEN online platform. Powered by GivePulse, Emory OPEN will enable users to list, find, organize, and measure the impact of service learning, community engagement and volunteerism in the community.

Below are four selected Winship publications out of 77 published over the past week:

Kelly KR, Ailawadhi S, Siegel DS, Heffner LT, Somlo G, Jagannath S, Zimmerman TM, Munshi NC, Madan S, Chanan-Khan A, Lonial S, Chandwani S, Minasyan A, Ruehle M, Barmaki-Rad F, Abdolzade-Bavil A, Rharbaoui F, Herrmann-Keiner E, Haeder T, Wartenberg-Demand A, Anderson KC. Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study. The Lancet. Haematology. 2021; PubMed PMID: 34529955.

View in PubMed

Kumar A, Hossain RA, Yost SA, Bu W, Wang Y, Dearborn AD, Grakoui A, Cohen JI, Marcotrigiano J. Structural insights into hepatitis C virus receptor binding and entry. Nature. 2021; PubMed PMID: 34526719.

View in PubMed

Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Martinez-Prieto M, Han X, Tiwari R, Salles G, Maziarz RT. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study. The Lancet. Oncology. 2021; PubMed PMID: 34516954.

View in PubMed

Zhu L, Chen Z, Zang H, Fan S, Gu J, Zhang G, Sun KD, Wang Q, He Y, Owonikoko TK, Ramalingam SS, Sun SY. Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib. Cancer Research. 2021; 81(18):4822-4834. PubMed PMID: 34289988.

View in PubMed